WallStSmart

HCA Holdings Inc (HCA)vsPACS Group, Inc. (PACS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HCA Holdings Inc generates 1329% more annual revenue ($75.60B vs $5.29B). HCA leads profitability with a 9.0% profit margin vs 3.6%. PACS appears more attractively valued with a PEG of 1.03. HCA earns a higher WallStSmart Score of 69/100 (B-).

HCA

Strong Buy

69

out of 100

Grade: B-

Growth: 7.3Profit: 8.0Value: 10.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.71

PACS

Buy

58

out of 100

Grade: C

Growth: 8.7Profit: 6.0Value: 10.0Quality: 3.5
Piotroski: 5/9Altman Z: 1.32
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HCAUndervalued (+59.9%)

Margin of Safety

+59.9%

Fair Value

$1326.31

Current Price

$484.02

$842.29 discount

UndervaluedFair: $1326.31Overvalued
PACSUndervalued (+31.4%)

Margin of Safety

+31.4%

Fair Value

$57.10

Current Price

$32.61

$24.49 discount

UndervaluedFair: $57.10Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HCA5 strengths · Avg: 9.0/10
Return on EquityProfitability
136.3%10/10

Every $100 of equity generates 136 in profit

Debt/EquityHealth
-8.3310/10

Conservative balance sheet, low leverage

Market CapQuality
$108.62B9/10

Large-cap with strong market position

P/E RatioValuation
17.1x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
44.5%8/10

Earnings expanding 44.5% YoY

PACS2 strengths · Avg: 9.5/10
EPS GrowthGrowth
57.2%10/10

Earnings expanding 57.2% YoY

Return on EquityProfitability
23.0%9/10

Every $100 of equity generates 23 in profit

Areas to Watch

HCA1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

PACS4 concerns · Avg: 2.8/10
P/E RatioValuation
27.6x4/10

Moderate valuation

Profit MarginProfitability
3.6%3/10

3.6% margin — thin

Free Cash FlowQuality
$-15.97M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
1.322/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : HCA

The strongest argument for HCA centers on Return on Equity, Debt/Equity, Market Cap. PEG of 1.35 suggests the stock is reasonably priced for its growth.

Bull Case : PACS

The strongest argument for PACS centers on EPS Growth, Return on Equity. Revenue growth of 12.4% demonstrates continued momentum. PEG of 1.03 suggests the stock is reasonably priced for its growth.

Bear Case : HCA

The primary concerns for HCA are Altman Z-Score.

Bear Case : PACS

The primary concerns for PACS are P/E Ratio, Profit Margin, Free Cash Flow. Debt-to-equity of 4.93 is elevated, increasing financial risk. Thin 3.6% margins leave little buffer for downturns.

Key Dynamics to Monitor

PACS is growing revenue faster at 12.4% — sustainability is the question.

HCA generates stronger free cash flow (870M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HCA scores higher overall (69/100 vs 58/100). PACS offers better value entry with a 31.4% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HCA Holdings Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.

Visit Website →

PACS Group, Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

PACS Group, Inc. is a leading technology solutions provider focused on enhancing operational efficiency and productivity across a wide array of industries. The company excels in developing innovative software and hardware systems that optimize workflows and enhance data management capabilities. With a strong commitment to research and development, PACS Group is well-positioned to capitalize on emerging technological trends, reinforcing its status as a key player in the digital transformation landscape. Its strategic partnerships and extensive market presence further strengthen its competitive advantage, presenting a compelling investment opportunity for institutional investors seeking growth in the evolving technology sector.

Visit Website →

Want to dig deeper into these stocks?